Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Euronext Paris  -  11:39:15 2023-01-27 am EST
89.55 EUR   -0.19%
01/27Sector Update: Health Care Stocks Flat to Lower Premarket Friday
MT
01/27Regeneron, Sanofi Say Dupixent Recommended for Expanded Approval in EU to Treat Atopic Dermatitis in Children
MT
01/27Sanofi, Regeneron Win EU Panel's Backing for Dupixent to Treat Atopic Dermatitis in Children
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about SANOFI
01/27Sanofi, Regeneron Win EU Panel's Backing for Dupixent to Treat Atopic Dermatitis in Chi..
MT
01/27Press Release : Dupixent« (dupilumab) recommended for expanded EU approval by the CHMP to ..
GL
01/27Press Release : Dupixent« (dupilumab) recommended for expanded EU approval by the CHMP to ..
AQ
01/26Sanofi Announces NEJM Publishes Data Demonstrating Clinically Meaningful Prevention of ..
CI
01/25Press Release : NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating i..
GL
01/25Press Release : NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating i..
AQ
01/25Sanofi Commences Dosing in a Phase 2 Study of SAR443820 in Individuals with Multiple Sc..
CI
01/25Innate Pharma Secures Antitrust Clearance for Expansion of Oncology Collaboration With ..
MT
01/25SANOFI : Receives a Buy rating from Goldman Sachs
MD
01/25SANOFI : Barclays reiterates its Neutral rating
MD
01/23Sanofi, CytoReason Expand Collaboration to Develop New Inflammatory Bowel Disease Resea..
MT
01/20Aptitude Health Appoints Jez Moulding as CEO
AQ
01/20SANOFI : Credit Suisse maintains a Buy rating
MD
01/19Sanofi Eyes 2023 Launch for Blood Disorder Treatment
MT
01/19Sanofi seeks to launch blood disorder drug this year - CNBC
RE
More most relevant news
All news about SANOFI
01/27Sector Update: Health Care Stocks Flat to Lower Premarket Friday
MT
01/27Regeneron, Sanofi Say Dupixent Recommended for Expanded Approval in EU to Treat Atopic ..
MT
01/27Sanofi, Regeneron Win EU Panel's Backing for Dupixent to Treat Atopic Dermatitis in Chi..
MT
01/27Sanofi's and Regeneron's Dupixent wins new stage of EU regulatory approval
RE
01/27Sanofi/Regeneron: Dupixent wins new stage of EU regulatory approval
RE
01/27Press Release : Dupixent« (dupilumab) recommended for expanded EU approval by the CHMP to ..
GL
01/27Press Release : Dupixent« (dupilumab) recommended for expanded EU approval by the CHMP to ..
AQ
01/26Sanofi Announces NEJM Publishes Data Demonstrating Clinically Meaningful Prevention of ..
CI
01/25Press Release : NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating i..
GL
01/25Press Release : NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating i..
AQ
More news
News in other languages on SANOFI
01/27WOCHENVORSCHAU: Termine bis 10. Februar 2023
01/27Beursagenda: buitenlandse fondsen
01/27WOCHENVORSCHAU/30. Januar bis 5. Februar (5. KW)
01/27Mise à jour sectorielle : Les actions du secteur de la santé son..
01/27Sanofi : avis positif du CHMP pour le traitement de la dermatite
01/27Sanofi : un avis favorable du CHMP dans la dermatite
01/27Le Dupixent de Sanofi et Regeneron obtient un nouvel avis favorable de l'UE
01/27Sanofi : le CHMP recommande une extension des indications du Dupixent dans l'UE
01/27Sanofi et Regeneron obtiennent l'aval du panel de l'UE pour le Dupixent dans le traitem..
01/27Communiqué De Presse : Le CHMP recommande l'extension des indications de Dupixent« (dupilu..
More news
Analyst Recommendations on SANOFI
01/25SANOFI : Receives a Buy rating from Goldman Sachs
MD
01/25SANOFI : Barclays reiterates its Neutral rating
MD
01/20SANOFI : Credit Suisse maintains a Buy rating
MD
01/18SANOFI : Buy rating from JP Morgan
MD
01/09SANOFI : UBS sticks Neutral
MD
More recommendations
Press releases
01/27Press Release : Dupixent« (dupilumab) recommended for expanded EU approval by the CHMP to ..
GL
01/27Press Release : Dupixent« (dupilumab) recommended for expanded EU approval by the CHMP to ..
AQ
01/25Press Release : NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating i..
GL
01/25Press Release : NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating i..
AQ
01/20Aptitude Health Appoints Jez Moulding as CEO
AQ
More press releases
Upcoming event on SANOFI